160 results
Page 4 of 8
8-K
EX-99.3
o8pq roh7kgz8
6 May 21
Trevena Reports First Quarter 2021 Results
7:05am
8-K
EX-99.2
69m9x
21 Apr 21
Regulation FD Disclosure
7:05am
8-K
EX-99.1
xyjtc2 uhgdzs1urao7
18 Mar 21
Trevena, Inc. Appoints Marvin H. Johnson, Jr. to Board of Directors
7:01am
8-K
EX-99.2
qpeo11ia8 ws
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am
8-K
EX-99.1
abb7ivj7c0 ui31liz
9 Mar 21
Trevena, Inc. Reports Fourth Quarter and Full Year 2020 Results
7:02am
424B5
p69sl
31 Dec 20
Prospectus supplement for primary offering
4:57pm
8-K
EX-99.1
cm6klx700atgbc9enhep
2 Nov 20
Regulation FD Disclosure
9:22am
8-K
EX-99.1
lc5ictaf
30 Oct 20
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection
8:00am
424B5
yqbirsyr0wvb wzn
13 Aug 20
Prospectus supplement for primary offering
12:00am
424B5
2uyg1bl sphsadl
11 Aug 20
Prospectus supplement for primary offering
4:23pm
8-K
EX-99.1
q48ip4 l2z7a7wh0x
10 Aug 20
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
6:24am
8-K
EX-99.2
wmjyy
10 Aug 20
Trevena Announces FDA Approval of OLINVYK™ (oliceridine) injection
6:24am
8-K
hvbv22 5nkr
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
EX-99.2
sfswn
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
EX-99.1
7uqzedy56nynee0vlzk
2 Jun 20
Trevena Announces Collaboration with Imperial College London to Evaluate TRV027 in COVID-19 Patients
7:00am
8-K
EX-99.1
82fmkl99v3u7i hjj8g
18 May 20
Regulation FD Disclosure
5:21pm
8-K
7291t 9tbtv1xgs
18 May 20
Regulation FD Disclosure
7:00am